Skip to main content

Prelude Therapeutics Inc

PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001678660

No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Prelude Therapeutics Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+8 vs. Q4 2025
Shares held
30.8M
+3.71M (+13.7%) vs. Q4 2025
Total value
$105.2M
+$26.8M (+34.1%) vs. Q4 2025
New holders
13
20 more added
Sold out
5
11 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 55 institutions
Q1 2021: 60 institutionsQ2 2021: 57 institutionsQ3 2021: 61 institutionsQ4 2021: 75 institutionsQ1 2022: 68 institutionsQ2 2022: 62 institutionsQ3 2022: 53 institutionsQ4 2022: 60 institutionsQ1 2023: 55 institutionsQ2 2023: 55 institutionsQ3 2023: 60 institutionsQ4 2023: 56 institutionsQ1 2024: 58 institutionsQ2 2024: 61 institutionsQ3 2024: 70 institutionsQ4 2024: 62 institutionsQ1 2025: 59 institutionsQ2 2025: 50 institutionsQ3 2025: 47 institutionsQ4 2025: 48 institutionsQ1 2026: 55 institutionsQ2 2026: 75 institutions
Value heldQ1 2026: $105.2M
Q1 2021: $1.41BQ2 2021: $986.6MQ3 2021: $1.12BQ4 2021: $437.6MQ1 2022: $235.4MQ2 2022: $170.9MQ3 2022: $210.3MQ4 2022: $188.3MQ1 2023: $179.6MQ2 2023: $176.2MQ3 2023: $113.1MQ4 2023: $148.3MQ1 2024: $162.1MQ2 2024: $129.2MQ3 2024: $74.0MQ4 2024: $41.0MQ1 2025: $23.3MQ2 2025: $22.0MQ3 2025: $39.1MQ4 2025: $82.6MQ1 2026: $105.2MQ2 2026: $264.3M
Institutions holding PRLD and their total value by quarter
QuarterHoldersValue
Q2 202675$264.3M
Q1 202655$105.2M
Q4 202548$82.6M
Q3 202547$39.1M
Q2 202550$22.0M
Q1 202559$23.3M
Q4 202462$41.0M
Q3 202470$74.0M
Q2 202461$129.2M
Q1 202458$162.1M
Q4 202356$148.3M
Q3 202360$113.1M
Q2 202355$176.2M
Q1 202355$179.6M
Q4 202260$188.3M
Q3 202253$210.3M
Q2 202262$170.9M
Q1 202268$235.4M
Q4 202175$437.6M
Q3 202161$1.12B
Q2 202157$986.6M
Q1 202160$1.41B

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q4 2025.

Institutions holding PRLD in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC10,909,256$37.3M0.85%00.0%Unchanged
Baker Bros. Advisors LP10,123,824$34.6M0.20%00.0%Unchanged
Kynam Capital Management, LP1,592,551$5.45M0.35%+803,684+101.9%Added
Vanguard Capital Management LLC1,230,406$4.21M0.00%+1,230,406New
EcoR1 Capital, LLC947,049$3.24M0.14%+947,049New
Two Sigma Investments, LP923,626$3.16M0.00%+134,931+17.1%Added
Sphera Funds Management Ltd.558,339$1.91M0.33%+435,587+354.9%Added
Acadian Asset Management LLC511,519$1.75M0.00%−24,184−4.5%Reduced
Millennium Management LLC382,737$1.31M0.00%+231,740+153.5%Added
Marshall Wace, LLP358,906$1.23M0.00%+85,023+31.0%Added
Morgan Stanley322,161$1.10M0.00%−12,755−3.8%Reduced
BlackRock, Inc.321,886$1.10M0.00%+55,606+20.9%Added
Geode Capital Management, LLC302,458$1.03M0.00%+29,572+10.8%Added
Renaissance Technologies LLC275,200$941.2K0.00%+3,900+1.4%Added
Susquehanna International Group, LLP267,788$915.8K0.00%+131,879+97.0%Added
Goldman Sachs Group Inc236,469$808.7K0.00%+118,992+101.3%Added
Jane Street Group, LLC192,963$659.9K0.00%+81,923+73.8%Added
Vanguard Fiduciary Trust Co157,380$538.2K0.00%+157,380New
ADAR1 Capital Management, LLC152,825$522.7K0.03%+152,825New
State Street Corp138,231$472.8K0.00%+10,939+8.6%Added
Citadel Advisors LLC124,378$425.4K0.00%+124,378New
Connor, Clark & Lunn Investment Management Ltd.109,085$373.1K0.00%+62,995+136.7%Added
UBS Group AG64,505$220.6K0.00%+62,648+3,373.6%Added
HRT Financial LP58,699$200.0K0.00%+58,699New
XTX Topco Ltd57,190$195.6K0.00%+7,031+14.0%Added
Bank of America Corp56,525$193.3K0.00%+46,717+476.3%Added
Bridgeway Capital Management, LLC53,500$183.0K0.00%00.0%Unchanged
Northern Trust Corp50,120$171.4K0.00%00.0%Unchanged
Colony Group, LLC50,007$171.0K0.00%00.0%Unchanged
Dimensional Fund Advisors LP35,210$119.7K0.00%+35,210New
Cerity Partners LLC32,875$112.4K0.00%−78−0.2%Reduced
Omers Administration Corp32,700$111.8K0.00%−40,300−55.2%Reduced
Prudential Financial Inc17,420$59.6K0.00%+1,900+12.2%Added
Qube Research & Technologies Ltd16,417$56.1K0.00%−5,134−23.8%Reduced
Point72 Asset Management, L.P.16,329$55.8K0.00%−42,839−72.4%Reduced
HSBC Holdings PLC13,652$47.9K0.00%00.0%Unchanged
Diametric Capital, LP11,980$41.0K0.01%+11,980New
Nine Masts Capital Ltd11,699$40.0K0.01%+11,699New
Graham Capital Management, L.P.11,343$38.8K0.00%+11,343New
American Century Companies Inc10,294$35.2K0.00%+10,294New
Barclays PLC8,600$29.4K0.00%−20.0%Reduced
FMR LLC6,009$20.6K0.00%−143−2.3%Reduced
Vanguard Global Advisers, LLC4,636$15.9K0.00%+4,636New
Group One Trading, L.P.3,907$13.4K0.00%+3,407+681.4%Added
SBI Securities Co., Ltd.2,641$9.03K0.00%−100−3.6%Reduced
Royal Bank of Canada2,331$8.00K0.00%+589+33.8%Added
Nisa Investment Advisors, LLC1,634$5.59K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.1,171$4.00K0.00%00.0%Unchanged
Caldwell Sutter Capital, Inc.1,000$3.42K0.00%−1,000−50.0%Reduced
CWM, LLC573$1.96K0.00%−119−17.2%Reduced
Fortitude Family Office, LLC230$7870.00%+230New
BNP Paribas Arbitrage, SA95$3250.00%00.0%Unchanged
JPMorgan Chase & Co62$1900.00%00.0%Unchanged
Optiver Holding B.V.20$680.00%00.0%Unchanged
Citigroup Inc5$170.00%+4+400.0%Added
Price T Rowe Associates Inc0$00.00%−755,956−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−237,300−100.0%Sold out
TD Asset Management Inc0$00.00%−160,652−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−70,546−100.0%Sold out
IFP Advisors, Inc0$00.00%−1−100.0%Sold out
Vanguard Group Inc––––Not filed